BrainTalk

Software for Detecting Cognitive Deficits

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
BrainTalk
NeuroPharmacology | NeuroBioTechnology
Digital & Health care
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Other
01/01/2016
"1-10"

BrainTalk is a software solution that detects cognitive deficits quickly and accurately based on a five-minute speech sample. BrainTalk has a patent-pending intelligent algorithm that can detect cognitive deficits from stroke, aging, disease, and medical interventions such as chemotherapy.



BrainTalk’s technology is designed to give health and sports organizations a noninvasive, cost-effective, and repeatable tool to screen and monitor large populations with known or suspected brain damage.



BrainTalk is the product of a collaboration between Israel’s National Institute for the Rehabilitation of the Brain Injured and the U.S.-based predictive analytics company SentiMetrix.